Table 4.
Correlation of extracellular vesicle (EV) concentration and percentage [%] of Annexin V+ EV with CK-MBmax in STEMI patients.
| Parameter | r | p-value |
|---|---|---|
| Total Annexin V+ EV/ml | 0.38 | 0.12 |
| CD61+ EV/ml | −0.09 | 0.72 |
| Caveolin-3+ EV/ml | 0.57 | 0.02 |
| CD45+ EV/ml | −−0.17 | 0.57 |
| CD62E+ EV/ml | 0.04 | 0.87 |
| CD235a+ EV/ml | 0.20 | 0.43 |
| CD61+ EV [%] | −−0.26 | 0.30 |
| Caveolin-3+ EV [%] | 0.50 | 0.04 |
| CD45+ EV [%] | −−0.25 | 0.39 |
| CD62E+ EV [%] | −−0.08 | 0.77 |
| CD235a+ EV [%] | −−0.16 | 0.54 |
CD61+ (platelet) EV, caveolin-3+ (cardiomyocyte) EV, CD45+ (leukocyte) EV, CD62E+ (endothelial) EV, CD235a+ (erythrocyte) EV. The Pearson correlation coefficient is presented. Significant p-values are indicated in bold.